Two-Drug Combo May Be Safe for Melanoma Treatment

<p>WEDNESDAY, May 16 (HealthDay News) — A preliminary, first-stage
study saved by a <span>pharmaceutical company</span> shows earnest formula for an
experimental double-drug therapy for <span>melanoma</span>. </p>
<p>The dual drugs, famous as dabrafenib and trametinib, seemed to delay
progression of a potentially lethal skin cancer with fewer <span>side effects</span>
than an existent drug called vemurafenib (Zelboraf). </p>
<p>However, a investigate into a drug multiple is usually in a initial of
three phases compulsory before a U.S. supervision can approve a use. The
first proviso is designed to exam a reserve of a medication, not possibly it
works.</p>
<p>Unlike some other cancers, cancer has stubbornly resisted advances in
treatment. About 70,000 Americans are diagnosed with cancer any year,
and about 8,000 of those will die from a disease.</p>
<p>Researchers tested a drug combo in patients wi...